Nurtec ODT

Migraine Treatment and Prevention

Nurtec ODT is used for two primary purposes related to migraine headaches in adults:

• Acute treatment: It is taken to treat the symptoms of a migraine attack once it has already started. This includes migraines that occur with or without an aura (sensory disturbances like flashes of light or blind spots that happen just before or during a headache).
• Preventive treatment: It is used as a preventive measure to reduce the frequency of episodic migraines, helping to decrease the number of days a person experiences a migraine.

Who It Is For

This medication is specifically indicated for adults. Healthcare providers typically prescribe it for individuals who experience episodic migraines, which are generally defined as having fewer than 15 headache days per month. It has not been studied or approved for use in children.

Limitations of Use

While Nurtec ODT is effective for migraine, it is not used to treat cluster headaches. It is intended to treat the migraine itself rather than being used as a general pain reliever for other types of headaches.

Mechanism of Action

Nurtec ODT belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) receptor antagonists. These medications are specifically designed to target a pathway in the nervous system that is involved in migraine development.

Blocking CGRP

During a migraine, the body releases a protein called CGRP around the brain. When this protein binds to its receptors, it causes blood vessels to dilate and leads to inflammation. This process is a primary cause of the throbbing pain, nausea, and sensitivity to light and sound that occur during an attack.

The active ingredient in Nurtec ODT, rimegepant, works by blocking these CGRP receptors. By preventing the protein from attaching to the receptors, the medication helps to:

• Reduce inflammation in the tissues surrounding the brain.
• Prevent blood vessels from over-dilating, which helps ease pressure.
• Stop pain signals from being transmitted through the trigeminal nerve, a major pain pathway for migraines.

By interfering with this process, the medication can stop a migraine that has already started or help prevent new ones from beginning when taken as directed.

Common Side Effects

The most common side effects reported by people taking Nurtec ODT include:

• Nausea
• Stomach pain or indigestion

Serious Side Effects

Serious allergic reactions are rare but can occur. You should seek emergency medical help if you have signs of an allergic reaction, including:

• Severe rash or hives
• Swelling of the face, lips, tongue, or throat
• Difficulty breathing or wheezing

Allergic reactions to Nurtec ODT can happen immediately or may be delayed, appearing days after the medication was taken. Contact your doctor if you experience any persistent or worsening symptoms.

Hypersensitivity Reactions

Serious allergic reactions, including anaphylaxis and angioedema, have been reported with the use of Nurtec ODT. These reactions can occur within minutes of taking a dose, but in some cases, they may develop days later. Symptoms of a serious reaction may include:

• Swelling of the face, lips, tongue, or throat
• Severe rash or hives
• Shortness of breath or difficulty breathing

If a serious hypersensitivity reaction occurs, the medication should be discontinued immediately.

Liver and Kidney Impairment

The use of Nurtec ODT is typically avoided in patients with certain underlying health conditions because the body may not be able to process the medication correctly:

• Severe Hepatic Impairment: Use is not recommended for individuals with severe liver disease.
• End-Stage Renal Disease: Use is not recommended for individuals with severe kidney failure or those requiring dialysis.

Drug Interactions

Certain medications can interfere with how Nurtec ODT is cleared from the body. This includes strong inhibitors or inducers of the CYP3A4 enzyme and inhibitors of certain transport proteins. These interactions may increase the risk of side effects or reduce the effectiveness of the treatment.

Pregnancy

It is currently unknown if Nurtec ODT can cause harm to an unborn baby or increase the risk of miscarriage. Data from human studies are insufficient to establish safety. In animal studies, some adverse effects on fetal development were observed, but only at doses significantly higher than those used in humans. A pregnancy exposure registry is available to monitor the health of individuals who take this medication while pregnant.

Breastfeeding

It is not fully known if Nurtec ODT passes into human breast milk or what effects it may have on a nursing infant. Limited data suggest that very small amounts of the drug may be present in breast milk, but the impact on the baby is not yet established. Healthcare providers typically weigh the benefits of treatment for the mother against the potential risks to the infant when deciding whether to continue the medication while breastfeeding.

Consulting Your Doctor

If you are pregnant, planning to become pregnant, or breastfeeding, it is important to talk to your doctor before using Nurtec ODT. They can help determine if the benefits of the medication outweigh the potential risks based on your specific health needs.

Available Forms

Nurtec ODT is supplied as an orally disintegrating tablet. This formulation is designed to be placed on or under the tongue, where it dissolves upon contact with saliva.

Packaging and Handling

The tablets are provided in blister packs to protect them from moisture. Because the medication is designed to dissolve rapidly, it should be handled with dry hands and removed from the blister pack only immediately before use.

FDA Approval and Indications

Nurtec ODT (rimegepant) is approved by the U.S. Food and Drug Administration (FDA) for two primary indications in adult patients: the acute treatment of migraine with or without aura and the preventive treatment of episodic migraine. It is the first medication in the calcitonin gene-related peptide (CGRP) receptor antagonist class to receive approval for both acute and preventive use.

Safety Monitoring and Regulatory Actions

The FDA monitors the safety of Nurtec ODT through the FDA Adverse Event Reporting System (FAERS). In early 2024, the FDA evaluated potential signals of serious risks related to hypersensitivity reactions, including rash and dyspnea (shortness of breath). After reviewing the available data, the FDA determined that no additional regulatory action was required at that time, as the existing product labeling already addresses the risk of hypersensitivity.

Boxed Warnings and REMS

There are currently no boxed warnings associated with Nurtec ODT. A boxed warning is the FDA’s most serious warning for medications with significant safety risks. Additionally, the FDA does not require a Risk Evaluation and Mitigation Strategy (REMS) for this drug.

Factors Influencing Cost

The price of Nurtec ODT can vary significantly based on several factors:

• Insurance Coverage: Many commercial insurance plans cover Nurtec ODT, though some may require prior authorization from a healthcare provider before the plan will pay for the prescription.
• Pharmacy Choice: Prices may differ between retail pharmacies, mail-order services, and specialty pharmacies.
• Treatment Plan: Because Nurtec ODT can be used both to treat active migraines and to prevent them, the number of tablets prescribed per month will affect the total cost.

Financial Assistance Programs

Since there is currently no generic version of rimegepant available, the out-of-pocket cost for the brand-name medication can be high. Several options may help reduce expenses:

• Manufacturer Savings Card: The drug manufacturer often offers a savings card for eligible patients with commercial insurance, which may reduce co-pays to a lower amount.
• Patient Assistance Programs: Programs may be available to provide the medication at low or no cost to individuals who are uninsured or underinsured and meet specific income requirements.

Patients are encouraged to check with their insurance provider and pharmacist to determine their specific out-of-pocket costs and to explore available financial support options.